ArticleCancer control : journal of the Moffitt Cancer Center

Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.

Łukasz Pietrzyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.